Skip to main content

Basile Edward M's Form 4 filing

TransMedics Group, Inc. (TMDX) · filed May 29, 2025

Accession no.
0000950170-25-079022
Filed
May 29, 2025
Trade date
May 27, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $632.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Basile Edward MCIK 0001773661Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 27, 2025Common StockMOption exerciseAcquired+5,000$0.70+$3,5007,866Direct
May 27, 2025Common StockSSaleDisposed−5,000$126.45−$632,2502,866Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 27, 2025Common StockMOption exerciseDisposed−5,000––8,285Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)